QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer 期刊论文 GYNECOLOGIC ONCOLOGY, 2019, 卷号: 153, 期号: 1 作者:  Yang, Bingyi;  Xu, Yuhui;  Zhu, Qin;  Xie, Liying;  Shan, Weiwei 收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05 Endometrial carcinoma  Endometrial atypical hyperplasia  Conservative treatment  Hysteroscopy   Comparison of the outcome between conventional mild stimulation and progestin-primed ovarian stimulation in women of advanced age: a retrospective study 会议论文 作者:  Peng, Q.;  Cao, X.;  Zhu, J.;  Dong, X. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response 期刊论文 CURRENT MEDICAL SCIENCE, 2019, 卷号: 39, 期号: 3 作者:  Xiao, Zhuo-ni;  Peng, Jia-li;  Yang, Jing;  Xu, Wang-ming 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 polycystic ovary syndrome  ovarian hyperstimulation syndrome  progestin-primed ovarian stimulation  GnRH antagonist protocol  controlled ovarian hyperstimulation   DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma 期刊论文 CANCER MEDICINE, 2019, 卷号: 8, 期号: 9, 页码: 4380-4388 作者:  Zhou, Qing;  Li, Wenzhi;  Kong, Deshui;  Liu, Zhiming;  Shi, Zhengzheng 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 bioinformatics  DACH1  EMT  endometrial carcinoma  progestin resistance   Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail 期刊论文 2019, 卷号: 35, 期号: 2, 页码: 165-169 作者:  Zhu, Shi-Yang;  Deng, Yan;  Wang, Yan-Fang;  Xue, Wei;  Ma, Xiao 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03 Hormone replacement therapy  postmenopausal osteoporosis  bone mineral density  conjugated equine estrogen